Sorry, no content matched your criteria.
Featured Story
Why Trillium (Nasdaq: TRIL) Stock Is Today's Top Biotech Buy
Trillium Therapeutics Inc. (Nasdaq: TRIL) stock has climbed 143% in 2015, and it's still one of the top biotech stocks to buy now.
You see, Trillium is at the forefront of a revolutionary treatment that could hold the key to curing various types of cancer.
Trillium Therapeutics Inc. (Nasdaq: TRIL) stock has climbed 143% in 2015, and it's still one of the top biotech stocks to buy now.
You see, Trillium is at the forefront of a revolutionary treatment that could hold the key to curing various types of cancer.